BCR Signaling Inhibitors Extremely Active and Generally Well Tolerated ASH 2015

BCR Signaling Inhibitors Extremely Active and Generally Well Tolerated ASH 2015

ASHReport

4 years
388 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Brian T. Hill , MD, PhD Assistant Professor, Medicine, Case Western Reserve University School of Medicine (Cleveland Clinic) discusses how BCR Signaling Inhibitors Extremely Active and Generally Well Tolerated from ASH 2015
Up Next Autoplay